Compare eBay Inc (EBAY) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
eBay Inc vs Novartis AG — how do they compare? eBay Inc trades at $111.47 (market cap $49.83B), while Novartis AG trades at $143.34 (market cap $268.57B). The key difference: Novartis AG is far larger — about 5.4× eBay Inc's market cap, and Novartis AG pays the higher dividend (3.31%). Which is the better fit depends on your goals — on Pluang, investors hold eBay Inc for 134 Days and Novartis AG for 82 Days on average.
| EBAY | NVS | |
|---|---|---|
Market Cap | $49.83B | $268.57B |
Volume | 2,986,953 | 1,532,573 |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $168.62 |
52-Week Low | $79.41 | $121.80 |
Typical Hold Time | 134 Days | 82 Days |
Enterprise Value | $53.65B | $309.89B |
Dividend Yield | 1.11% | 3.31% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
eBay (EBAY) trades at $107.6, up 0.5% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $117.68 implying upside. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Revenue growth is steady, reaching $11.10B in 2025, supported by strong profitability margins including a net income margin of 18.57% and an impressive ROE of 47.38%.
The outlook is positive, driven by earnings momentum and strategic focus on collectibles and live commerce, but risks include competitive pressures from Amazon's new multi-platform tools and potential volatility from GameStop's significant stake. Investor sentiment is mixed, with nearly equal buy and hold ratings from analysts.
Novartis (NVS) trades at $143.28, up 1.77% on the day, with a neutral technical signal and mixed earnings history. The company reported strong 2025 revenue of $56.67B and a net income margin of 22.5%, supported by a recent $7.8B licensing deal with China's Abogen. However, recent clinical trial setbacks and an ongoing law firm investigation introduce uncertainty.
The outlook is balanced; solid profitability and a consensus price target of $146.00 suggest modest upside, but risks from pipeline failures and heightened M&A scrutiny warrant caution. Investor sentiment is mixed, with analysts predominantly holding a neutral stance amid evolving business developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
